Gene therapies are in development for both SCN8A DEE and Dravet syndrome, and downregulation of Scn8a has been shown to reduce seizures in both disorders (80–82). Here, SCN8A is linked to encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.